This is further supported through clinical data from untreated CLL patients, showing a higher ratio of CD4+/CD8+ cells in the peripheral blood of NOTCH1 mutated patients compared to NOTCH-wild-type patients (Fig. 7j). The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.